ADGM
Adagio Medical Holdings Inc (ADGM)
Healthcare • NASDAQ • $0.98+2.31%
- Symbol
- ADGM
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $0.98
- Daily Change
- +2.31%
- Market Cap
- $21.66M
- Trailing P/E
- N/A
- Forward P/E
- -0.58
- 52W High
- $2.58
- 52W Low
- $0.74
- Analyst Target
- $3.50
- Dividend Yield
- N/A
- Beta
- -0.14
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Company websiteResearch ADGM on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.